Seladelpar for alkaline phosphatase normalization in primary biliary cholangitis: The IDEAL phase III randomized controlled trial. // Journal of Hepatology. – URL: https://www.sciencedirect.com/science/article/pii/S0168827826029879?dgcid=rss_sd_all
Seladelpar for alkaline phosphatase normalization in primary biliary cholangitis: The IDEAL phase III randomized controlled trial. Journal of Hepatology. https://www.sciencedirect.com/science/article/pii/S0168827826029879?dgcid=rss_sd_all
“Seladelpar for alkaline phosphatase normalization in primary biliary cholangitis: The IDEAL phase III randomized controlled trial.” Journal of Hepatology.
@article{article53468,
title = {Seladelpar for alkaline phosphatase normalization in primary biliary cholangitis: The IDEAL phase III randomized controlled trial},
journal = {Journal of Hepatology},
url = {https://www.sciencedirect.com/science/article/pii/S0168827826029879?dgcid=rss_sd_all}
}